Status:
RECRUITING
Holistic Mixed Approaches to Capture the Real Life of Children With Rare Eye Diseases
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Eye Diseases
Severe Loss of Vision
Eligibility:
All Genders
8+ years
Brief Summary
Rare Eye Diseases (RED) are the leading cause of severe visual impairment/ blindness (SVI/B) in children in Europe. This sensory disability with its accompanying psychological distress hugely impacts ...
Eligibility Criteria
Inclusion
- Children (age 8-12) and teenagers (age 13-18) with various levels of visual impairment defined according to World Health Organization (WHO) International Classification of Diseases (ICD) 10 - WHO ICD 10 \[best-corrected visual acuity ≤ 0.3 decimal or ≤ 6/18\], and their parents/caregivers.
Exclusion
- Children, teenagers, and caregivers:
- who lack the ability to respond in a reliable way to the questions on how they feel about their visual impairment (patients with mild intellectual or cognitive deficiency may be able to reply accurately as opposed to cases with severe intellectual disability)
- with functional or non-ophthalmic reasons of visual impairment
- unable to provide consent/assent;
- who do not speak/read the language
Key Trial Info
Start Date :
July 17 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT06070467
Start Date
July 17 2024
End Date
July 1 2026
Last Update
August 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Référence pour les Affections Rares en Génétique Ophtalmologique (CARGO), Hôpitaux Universitaires
Strasbourg, France, 67091